Wulfkuhle JD - Search Results

1

Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIAL.

Olshen A, Wolf D, Jones EF, Newitt D, van ‘t Veer LJ, Yau C, Esserman L, Wulfkuhle JD, Gallagher RI, Singer L, Petricoin EF 3rd, Hylton N, Park CC. Olshen A, et al. Among authors: wulfkuhle jd. J Med Imaging (Bellingham). 2018 Jan;5(1):011014. doi: 10.1117/1.JMI.5.1.011014. Epub 2017 Dec 23. J Med Imaging (Bellingham). 2018. PMID: 29296631 Free PMC article.

2

Proteomic applications for the early detection of cancer.

Wulfkuhle JD, Liotta LA, Petricoin EF. Wulfkuhle JD, et al. Nat Rev Cancer. 2003 Apr;3(4):267-75. doi: 10.1038/nrc1043. Nat Rev Cancer. 2003. PMID: 12671665 Review.

3

Proteomic approaches to the diagnosis, treatment, and monitoring of cancer.

Wulfkuhle JD, Paweletz CP, Steeg PS, Petricoin EF 3rd, Liotta L. Wulfkuhle JD, et al. Adv Exp Med Biol. 2003;532:59-68. doi: 10.1007/978-1-4615-0081-0_7. Adv Exp Med Biol. 2003. PMID: 12908550 Review.

4

Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays.

Wulfkuhle JD, Aquino JA, Calvert VS, Fishman DA, Coukos G, Liotta LA, Petricoin EF 3rd. Wulfkuhle JD, et al. Proteomics. 2003 Nov;3(11):2085-90. doi: 10.1002/pmic.200300591. Proteomics. 2003. PMID: 14595806

5

Protein microarrays: molecular profiling technologies for clinical specimens.

Espina V, Mehta AI, Winters ME, Calvert V, Wulfkuhle J, Petricoin EF 3rd, Liotta LA. Espina V, et al. Proteomics. 2003 Nov;3(11):2091-100. doi: 10.1002/pmic.200300592. Proteomics. 2003. PMID: 14595807 Review.

6

STUDENTJAMA. Molecular technologies for personalized cancer management.

Hasan RK, Wulfkuhle JD, Liotta LA, Petricoin EF. Hasan RK, et al. Among authors: wulfkuhle jd. JAMA. 2004 Apr 7;291(13):1644-5. doi: 10.1001/jama.291.13.1644. JAMA. 2004. PMID: 15069056 No abstract available.

7

Protein microarray detection strategies: focus on direct detection technologies.

Espina V, Woodhouse EC, Wulfkuhle J, Asmussen HD, Petricoin EF 3rd, Liotta LA. Espina V, et al. J Immunol Methods. 2004 Jul;290(1-2):121-33. doi: 10.1016/j.jim.2004.04.013. J Immunol Methods. 2004. PMID: 15261576 Review.

8

Genomic and proteomic technologies for individualisation and improvement of cancer treatment.

Wulfkuhle J, Espina V, Liotta L, Petricoin E. Wulfkuhle J, et al. Eur J Cancer. 2004 Nov;40(17):2623-32. doi: 10.1016/j.ejca.2004.05.020. Eur J Cancer. 2004. PMID: 15541963 Review.

9

Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma.

Sheehan KM, Calvert VS, Kay EW, Lu Y, Fishman D, Espina V, Aquino J, Speer R, Araujo R, Mills GB, Liotta LA, Petricoin EF 3rd, Wulfkuhle JD. Sheehan KM, et al. Among authors: wulfkuhle jd. Mol Cell Proteomics. 2005 Apr;4(4):346-55. doi: 10.1074/mcp.T500003-MCP200. Epub 2005 Jan 25. Mol Cell Proteomics. 2005. PMID: 15671044 Free article. Review.

10

Reverse-phase protein microarrays for tissue-based analysis.

Speer R, Wulfkuhle JD, Liotta LA, Petricoin EF 3rd. Speer R, et al. Among authors: wulfkuhle jd. Curr Opin Mol Ther. 2005 Jun;7(3):240-5. Curr Opin Mol Ther. 2005. PMID: 15977421 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters